Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A cross comparison between Ayurvedic etiology of Major Depressive Disorder and bidirectional effect of gut dysregulation.

Steer E.

J Ayurveda Integr Med. 2019 Jan 14. pii: S0975-9476(17)30231-0. doi: 10.1016/j.jaim.2017.08.002. [Epub ahead of print] Review.

2.

Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca2+ handling dysfunction in rats with pulmonary artery hypertension.

Fowler ED, Drinkhill MJ, Norman R, Pervolaraki E, Stones R, Steer E, Benoist D, Steele DS, Calaghan SC, White E.

J Mol Cell Cardiol. 2018 Jul;120:74-83. doi: 10.1016/j.yjmcc.2018.05.015. Epub 2018 May 26.

3.

Simvastatin activates single skeletal RyR1 channels but exerts more complex regulation of the cardiac RyR2 isoform.

Venturi E, Lindsay C, Lotteau S, Yang Z, Steer E, Witschas K, Wilson AD, Wickens JR, Russell AJ, Steele D, Calaghan S, Sitsapesan R.

Br J Pharmacol. 2018 Mar;175(6):938-952. doi: 10.1111/bph.14136. Epub 2018 Feb 5.

4.

Determination of Geochemical Bio-Signatures in Mars-Like Basaltic Environments.

Olsson-Francis K, Pearson VK, Steer ED, Schwenzer SP.

Front Microbiol. 2017 Sep 8;8:1668. doi: 10.3389/fmicb.2017.01668. eCollection 2017.

5.

Controlling the Release of Indomethacin from Glass Solutions Layered with a Rate Controlling Membrane Using Fluid-Bed Processing. Part 1: Surface and Cross-Sectional Chemical Analysis.

Dereymaker A, Scurr DJ, Steer ED, Roberts CJ, Van den Mooter G.

Mol Pharm. 2017 Apr 3;14(4):959-973. doi: 10.1021/acs.molpharmaceut.6b01023. Epub 2017 Feb 28.

PMID:
28206770
6.

PKA Phosphorylation of NCLX Reverses Mitochondrial Calcium Overload and Depolarization, Promoting Survival of PINK1-Deficient Dopaminergic Neurons.

Kostic M, Ludtmann MH, Bading H, Hershfinkel M, Steer E, Chu CT, Abramov AY, Sekler I.

Cell Rep. 2015 Oct 13;13(2):376-86. doi: 10.1016/j.celrep.2015.08.079. Epub 2015 Oct 1.

7.

Beyond mitophagy: cytosolic PINK1 as a messenger of mitochondrial health.

Steer EK, Dail MK, Chu CT.

Antioxid Redox Signal. 2015 Apr 20;22(12):1047-59. doi: 10.1089/ars.2014.6206. Epub 2015 Feb 18. Review.

8.

Mutant LRRK2 enhances glutamatergic synapse activity and evokes excitotoxic dendrite degeneration.

Plowey ED, Johnson JW, Steer E, Zhu W, Eisenberg DA, Valentino NM, Liu YJ, Chu CT.

Biochim Biophys Acta. 2014 Sep;1842(9):1596-603. doi: 10.1016/j.bbadis.2014.05.016. Epub 2014 May 27.

9.

ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease.

Verma M, Steer EK, Chu CT.

Biochim Biophys Acta. 2014 Aug;1842(8):1273-81. doi: 10.1016/j.bbadis.2013.11.005. Epub 2013 Nov 10. Review.

10.

Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells.

Chu CT, Ji J, Dagda RK, Jiang JF, Tyurina YY, Kapralov AA, Tyurin VA, Yanamala N, Shrivastava IH, Mohammadyani D, Wang KZQ, Zhu J, Klein-Seetharaman J, Balasubramanian K, Amoscato AA, Borisenko G, Huang Z, Gusdon AM, Cheikhi A, Steer EK, Wang R, Baty C, Watkins S, Bahar I, Bayir H, Kagan VE.

Nat Cell Biol. 2013 Oct;15(10):1197-1205. doi: 10.1038/ncb2837. Epub 2013 Sep 15.

11.

Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons.

Cherra SJ 3rd, Steer E, Gusdon AM, Kiselyov K, Chu CT.

Am J Pathol. 2013 Feb;182(2):474-84. doi: 10.1016/j.ajpath.2012.10.027. Epub 2012 Dec 8.

12.

The trials and tribulations of doing drug research in children.

Matsui D, Kwan C, Steer E, Rieder MJ.

CMAJ. 2003 Nov 11;169(10):1033-4. No abstract available.

13.

Where physicians look for information on drug prescribing for children.

Matsui DM, Jardine ME, Steer E, Cukernik V, Rieder MJ.

Paediatr Child Health. 2003 Apr;8(4):219-21.

14.

A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion.

Billio A, Steer EJ, Pianezze G, Svaldi M, Casin M, Amato B, Coser P, Cross NC.

Haematologica. 2002 May;87(5):ECR15. No abstract available.

PMID:
12010678
15.
16.

The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins.

Demiroglu A, Steer EJ, Heath C, Taylor K, Bentley M, Allen SL, Koduru P, Brody JP, Hawson G, Rodwell R, Doody ML, Carnicero F, Reiter A, Goldman JM, Melo JV, Cross NC.

Blood. 2001 Dec 15;98(13):3778-83.

17.

ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia.

de la Fuente J, Merx K, Steer EJ, Müller M, Szydlo RM, Maywald O, Berger U, Hehlmann R, Goldman JM, Cross NC, Melo JV, Hochhaus A; German CML Study Group.

Blood. 2001 Nov 1;98(9):2879-80. No abstract available.

18.

Mutations of the transcription factor AML1/CBFA2 are uncommon in blastic transformation of chronic myeloid leukaemia.

Steer EJ, Goldman JM, Cross NC.

Leukemia. 2001 Mar;15(3):476-7. No abstract available.

PMID:
11237075

Supplemental Content

Support Center